Found: 18
Select item for more details and to access through your institution.
The effect of electronic medical record system sophistication on preventive healthcare for women.
- Published in:
- Journal of the American Medical Informatics Association, 2013, v. 20, n. 2, p. 268, doi. 10.1136/amiajnl-2012-001099
- By:
- Publication type:
- Article
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE.
- Published in:
- Rheumatology, 2021, v. 60, n. 12, p. 5583, doi. 10.1093/rheumatology/keab158
- By:
- Publication type:
- Article
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY.
- Published in:
- Rheumatology, 2021, v. 60, n. 7, p. 3209, doi. 10.1093/rheumatology/keaa770
- By:
- Publication type:
- Article
Direct Costs in Patients with Celiac Disease in the USA: A Retrospective Claims Analysis.
- Published in:
- Digestive Diseases & Sciences, 2016, v. 61, n. 10, p. 2823, doi. 10.1007/s10620-016-4219-x
- By:
- Publication type:
- Article
Direct and indirect resource use, healthcare costs and work force absence in patients with non-infectious intermediate, posterior or panuveitis.
- Published in:
- Acta Ophthalmologica (1755375X), 2016, v. 94, n. 5, p. e331, doi. 10.1111/aos.12987
- By:
- Publication type:
- Article
The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2011, v. 20, n. 8, p. 866, doi. 10.1002/pds.2150
- By:
- Publication type:
- Article
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1519, doi. 10.1007/s40744-023-00594-6
- By:
- Publication type:
- Article
Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-2037-1
- By:
- Publication type:
- Article
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-2059-8
- By:
- Publication type:
- Article
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 12, p. 5649, doi. 10.1007/s12325-021-01930-4
- By:
- Publication type:
- Article
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Authors' Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names.
- Published in:
- Advances in Therapy, 2015, v. 32, n. 3, p. 270, doi. 10.1007/s12325-015-0193-5
- By:
- Publication type:
- Article
Correction: Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02813-x
- By:
- Publication type:
- Article